What Happened?
Boston, MA-based Prilenia Appointed Michael Hayden as Chief Executive Officer
About the Company
We are a clinical stage biotech startup, led by Michael Hayden, MD, PhD., together with a highly experienced team with a track record of success. Michael is the founder of five biotech companies and was previously President of Global R&D and Chief Scientific Officer at Teva. He has directed the development of multiple innovative drug products leading to 35 approvals between 2012-2018.
About the Person
Michael Hayden is Chief Executive Officer at Prilenia. Previously, Michael held various senior HR leadership roles in the industry.
Info Source
News
Short Profile